Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
November 18, 2003
Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a small molecule antagonist of the neuropeptide Y Y2 receptor
Pascal Bonaventure, Diane Nepomuceno, Curt Mazur, et al.
BMC Genomics
|
March 2, 2019
A modular analysis of microglia gene expression, insights into the aged phenotype
Christine E Cho, Sagar S Damle, Edward V Wancewicz, et al.
Experimental Neurology
|
April 3, 2018
Time-dependent, bidirectional, anti- and pro-spinal hyper-reflexia and muscle spasticity effect after chronic spinal glycine transporter 2 (GlyT2) oligonucleotide-induced downregulation
Kota Kamizato, Silvia Marsala, Michael Navarro, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 24, 2002
Novel human histamine H(3) receptor antagonists
Chandra Shah, Laura McAtee, J Guy Breitenbucher, et al.
Toxicologic Pathology
|
January 5, 2024
Toxicologic Pathology Forum: Opinion on Interpretive Challenges for Procedure-Related Effects Associated With Direct Central Nervous System Delivery of Oligonucleotides to Rodents, Dogs, and Nonhuman Primates
Lisa D Berman-Booty, Stephanie K Klein, Curt Mazur, et al.
The Journal of Clinical Investigation
|
February 15, 2024
Interferon-α receptor antisense oligonucleotides reduce neuroinflammation and neuropathology in a mouse model of cerebral interferonopathy
Barney Viengkhou, Christine Hong, Curt Mazur, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 4, 2007
Dual serotonin transporter inhibitor/histamine H3 antagonists: development of rigidified H3 pharmacophores
John M Keith, Ann J Barbier, Sandy J Wilson, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 23, 2007
Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitors
John M Keith, Leslie A Gomez, Ann J Barbier, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2003
Non-imidazole heterocyclic histamine H3 receptor antagonists
Wenying Chai, J Guy Breitenbucher, Annette Kwok, et al.
Elife
|
May 27, 2025
An antisense oligonucleotide-based strategy to ameliorate cognitive dysfunction in the 22q11.2 Deletion Syndrome
Pratibha Thakur, Martin Lackinger, Anastasia Diamantopoulou, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
The Journal of Pharmacology and Experimental Therapeutics
|
November 18, 2003
Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a small molecule antagonist of the neuropeptide Y Y2 receptor
Pascal Bonaventure, Diane Nepomuceno, Curt Mazur, et al.
BMC Genomics
|
March 2, 2019
A modular analysis of microglia gene expression, insights into the aged phenotype
Christine E Cho, Sagar S Damle, Edward V Wancewicz, et al.
Experimental Neurology
|
April 3, 2018
Time-dependent, bidirectional, anti- and pro-spinal hyper-reflexia and muscle spasticity effect after chronic spinal glycine transporter 2 (GlyT2) oligonucleotide-induced downregulation
Kota Kamizato, Silvia Marsala, Michael Navarro, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 24, 2002
Novel human histamine H(3) receptor antagonists
Chandra Shah, Laura McAtee, J Guy Breitenbucher, et al.
Toxicologic Pathology
|
January 5, 2024
Toxicologic Pathology Forum: Opinion on Interpretive Challenges for Procedure-Related Effects Associated With Direct Central Nervous System Delivery of Oligonucleotides to Rodents, Dogs, and Nonhuman Primates
Lisa D Berman-Booty, Stephanie K Klein, Curt Mazur, et al.
The Journal of Clinical Investigation
|
February 15, 2024
Interferon-α receptor antisense oligonucleotides reduce neuroinflammation and neuropathology in a mouse model of cerebral interferonopathy
Barney Viengkhou, Christine Hong, Curt Mazur, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 4, 2007
Dual serotonin transporter inhibitor/histamine H3 antagonists: development of rigidified H3 pharmacophores
John M Keith, Ann J Barbier, Sandy J Wilson, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 23, 2007
Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitors
John M Keith, Leslie A Gomez, Ann J Barbier, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2003
Non-imidazole heterocyclic histamine H3 receptor antagonists
Wenying Chai, J Guy Breitenbucher, Annette Kwok, et al.
Elife
|
May 27, 2025
An antisense oligonucleotide-based strategy to ameliorate cognitive dysfunction in the 22q11.2 Deletion Syndrome
Pratibha Thakur, Martin Lackinger, Anastasia Diamantopoulou, et al.
Page
of 4